To the Editor A specific regulatory role of prostaglandin E 2 (PGE 2 ) was postulated in aspirin--induced asthma. 1 Indeed, in this distinct asthma phenotype, several observations have accumulated pointing to depressed PGE 2 production by peripheral blood cells, nasal polyps, and bronchial fibroblasts; diminished EP 2 receptor expression on the inflammatory cells; and the association of EP 2 gene polymorphism with aspirin hypersensitivity.
2
We performed inhalation challenge with increasing doses of lysine aspirin 2 in 14 patients with aspirin-induced asthma and 11 asthmatics who tolerated aspirin well. The mean age of the patients was 44.3 years, and the groups did not differ in their main clinical characteristics. In all subjects, exhaled breath condensates (EBC) were collected at baseline.
3 The collection was repeated at the time of appearance of the bronchial symptoms in subjects with aspirin-induced asthma, and when the cumulative dose of 182 mg of aspirin was reached in aspirin-tolerant asthmatics. In EBC samples, PGE 2 and its main metabolite (tetranor-PGEM) were measured using gas chromatography / mass spectrometry (GC/MS) and high-performance liquid chromatography/tandem mass spectrometry (HPLC/MS/MS), respectively. The results were expressed as raw concentration per 1 ml and as parts per million palmitic acid. 3 Aspirin precipitated bronchial reactions in all subjects with aspirin-induced asthma, but in no subjects from the aspirin-tolerant group. At baseline, mean PGE 2 values did not differ between the groups, while tetranor-PGEM was higher in subjects with aspirin-induced asthma compared with the other group (P <0.001). Following aspirin challenge, the mean values remained unchanged (TabLE) . The dose of aspirin had no effect on the response of PGE 2 and its metabolite. There was a positive correlation between the levels of PGE 2 and tetranor--PGEM following aspirin challenge only in aspirin--tolerant subjects (r = 0.93, P <0.001).
Our results add to the observations on the changes in prostaglandin production in aspirin--induced asthma 2,4-6 and indicate a rapid catabolism of PGE 2 in the lungs -its rate is 4-fold higher in aspirin-induced than in aspirin-tolerant asthma. The upregulation of the enzymes metabolizing PGE 2 might be related to a specific proinflammatory milieu operating in the bronchi of patients with aspirin-induced asthma.
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